Clinically, SMA is divided into different subtypes on the basis of severity and age of onset and variation in the copy number of SMN2 determine most of the phenotypic variability in patients (3) and in mouse models (4). This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.